Transaction #18017 · Form 4 · 0001493152-25-027107
Immix Biopharma, Inc. · Other acquisition · Common Stock
Immix Biopharma, Inc. · Transacted December 8, 2025 · Filed December 10, 2025
What does this filing report?
An SEC Form 4 filing for Immix Biopharma, Inc. records an other acquisition involving Common Stock on December 8, 2025. The reported quantity was 156,000. The filing date is December 10, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Immix Biopharma, Inc.
- Company CIK
- 0001873835
- Security type
- Non-derivative
- Acquisition type
- Other acquisition · Code X
- Quantity acquired
- 156,000
- Reported price
- 0.8
- Reference value
- 124,800
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 426,844
- Ownership description
- See footnote
- SEC acceptance time
- Dec 10, 2025, 6:47 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Morris Gabriel S ↗
CFO · Director
CIK 0001889967
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
- F2
- Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.
- F3
- The warrants were held by Alwaysraise LLC.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.